NCT03626870

Withdrawn

Effects of Resistin on Neutrophil Function

Milton S. Hershey Medical Center Source

Compare

Other study identifiers

Sponsor study identifier

STUDY00010357

Study Type

observational

Actual enrollment (reported)

0

Locations

1 country

Sites

1

Timeline

Study Start

September 1, 2018

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

September 1, 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

September 1, 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

To assess the effect of resistin on neutrophil migration and intracellular bacterial killing

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: withdrawn
Actual enrollment (reported): 0 participants
Study completion date: September 1, 2019
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
August 3, 2018
Actual (reported)
First Posted
August 13, 2018
Actual (reported)
Study Start
September 1, 2018
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
September 1, 2019
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 1, 2019
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: December 10, 2024
Status Verified: March 2023
Last Update Submitted: December 5, 2024

Conditions

Inflammation

Outcome Measures

Primary Outcomes (1)

intracellular bacterial killing, assessed by number of colonies of bacterial growth following neutrophil exposure to bacteria and resistin
6 months

Eligibility Criteria

Age18 Years - 100 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

all healthy volunteer adults

You may qualify if:

age ≥ 18

Sponsors & Collaborators

Milton S. Hershey Medical Center
Otherlead

Study Sites (1)

Penn State Milton S Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Anthony Bonavia, MD
Penn State Milton S Hershey Med Ctr
PRINCIPAL INVESTIGATOR

Enrollment

0 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Professor, Department of Anesthesiology

Study Record Dates

First Submitted

August 3, 2018

First Posted

August 13, 2018

Study Start

September 1, 2018

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

NCT04034160

Beef Burger Versus a Vegetarian Burger

Not ApplicableCompleted

NCT04600765

hsCRP Clinical Inflammation Marker for Human Bisphenol A Food Contamination

Not ApplicableCompleted

NCT04177264

Anti-inflammatory Actions of Osteopathic Manipulative Treatment

Not ApplicableUnknown

NCT02938650

Nitrosomonas Eutropha on Nitrolipids in the Skin

Phase 1Completed

NCT02676466

The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study

Phase 2Completed

NCT04819646

Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort

Not ApplicableCompleted

gender: male or female

You may not qualify if:

Adults who are unable to provide informed consent themselves
History of chronic kidney disease as defined by estimated glomerular filtration rate (GFR) \<60 ml/min prior to cardiogenic shock
Patients with hematologic malignancies
Pregnant women
Patient/surrogate is not fluent in English
Long-term immunosuppressive therapy
Prisoner
Patients on pre-existing continuous reno-renal therapy (CRRT) or intermittent hemodialysis (IHD

Contact the study team to confirm eligibility.

Primary Completion

September 1, 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

September 1, 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

December 10, 2024

Record last verified: 2023-03

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03626870
Data provider: ClinicalTrials.gov
Source updated: 2024-12-10
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:30:29 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations